| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 82 |
| 1 | PREDNISOLONE ORAL | 82 |
| 2 | PREDNISOLONE ORAL SOLUTION | 82 |
| 3 | CYCLOPHOSPHAMIDE | 68 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 68 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 68 |
| 6 | RITUXIMAB | 68 |
| 7 | AZATHIOPRINE | 67 |
| 8 | MYCOPHENOLATE MOFETIL | 67 |
| 9 | FUROSEMIDE | 62 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAZOSIN HYDROCHLORIDE | 40 | 0.0288 |
| 1 | HYDRALAZINE HYDROCHLORIDE | 41 | 0.0153 |
| 2 | CEFOTETAN DISODIUM | 1 | 0.0089 |
| 3 | CAFFEINE, MAGNESIUM SALICYLATE | 2 | 0.0079 |
| 4 | CEFOTETAN | 1 | 0.0075 |
| 5 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 6 | LULICONAZOLE | 1 | 0.0057 |
| 7 | PAMABROM | 2 | 0.0055 |
| 8 | VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE | 1 | 0.0054 |
| 9 | ISRADIPINE | 2 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 155 |
| 1 | Alkylating Drug [EPC] | 79 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 68 |
| 3 | Purine Antimetabolite [EPC] | 67 |
| 4 | Loop Diuretic [EPC] | 65 |
| 5 | Alkaloid [EPC] | 57 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 53 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 52 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 51 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 49 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkaloid [EPC] | 57 | 0.0021 |
| 1 | Vitamin D3 Analog [EPC] | 42 | 0.0021 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 42 | 0.0020 |
| 3 | Erythropoiesis-stimulating Agent [EPC] | 49 | 0.0009 |
| 4 | Purine Antimetabolite [EPC] | 67 | 0.0007 |
| 5 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 43 | 0.0004 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 8 | 0.0004 |
| 7 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 12 | 0.0004 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 6 | 0.0004 |